Abstract
Autophagy is an evolutionarily conserved process of cellular self-degradation and recycling of redundant cytoplasmic entities by lysosomal enzymes. Moreover, autophagy also plays critical roles in controlling several biochemical and molecular neuronal physiology such as growth, survival and metabolism. The autophagy process constantly occurs at basal level under normal physiological conditions and gets increased during stress conditions such as starvation and hypoxia. In neuronal cells, it is a vital homeostasis mechanism that helps in the maintenance of protein quality control. In various neurological disorders, several crucial pro-survival and anti-apoptotic effects of autophagy have been reported. However, the function of autophagy in ischaemic stroke (IS) is highly controversial and still debated. Some reports show that it protects neurons during IS, while others advocate it to be neurodegenerative. Thus, the present chapter deals with the possible function of autophagy in ischaemic stroke along with the discussion of various factors influencing the action of autophagy in ischaemic stroke.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chu, C. T. (2008, February). Eaten alive. The American Journal of Pathology, 172(2), 284–287.
Lakhan, S. E., Kirchgessner, A., & Hofer, M. (2009). Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. Journal of Translational Medicine, 7(1), 97.
Cowan, F., Rutherford, M., Groenendaal, F., Eken, P., Mercuri, E., Bydder, G. M., et al. (2003, March). Origin and timing of brain lesions in term infants with neonatal encephalopathy. The Lancet, 361(9359), 736–742.
Block, F. (1999, June). Global ischemia and behavioural deficits. Progress in Neurobiology, 58(3), 279–295.
Ouyang, Y. B., & Giffard, R. G. (2012). ER-mitochondria crosstalk during cerebral ischemia: Molecular chaperones and ER-mitochondrial calcium transfer. International Journal of Cell Biology, 2012, 1–8.
Carron, S. F., Alwis, D. S., & Rajan, R. (2016, June). Traumatic brain injury and neuronal functionality changes in sensory cortex. Frontiers in Systems Neuroscience, 10, 47. Available from: http://journal.frontiersin.org/Article/10.3389/fnsys.2016.00047/abstract
Petty, G. W., Brown, R. D., Whisnant, J. P., Sicks, J. D., O’Fallon, W. M., & Wiebers, D. O. (2000, May 1). Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence. Stroke, 31(5), 1062–1068.
Sanganalmath, S. K., Gopal, P., Parker, J. R., Downs, R. K., Parker, J. C., & Dawn, B. (2017, February). Global cerebral ischemia due to circulatory arrest: Insights into cellular pathophysiology and diagnostic modalities. Molecular and Cellular Biochemistry, 426(1–2), 111–127.
Ye, Y., Perez-Polo, J. R., & Birnbaum, Y. (2010, October). Protecting against ischemia-reperfusion injury: Antiplatelet drugs, statins, and their potential interactions: Ye et al. The Annals of the New York Academy of Sciences, 1207(1), 76–82.
Balucani, C., Levine, S. R., Khoury, J. C., Khatri, P., Saver, J. L., & Broderick, J. P. (2016, April). Acute ischemic stroke with very early clinical improvement: A National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator stroke trials exploratory analysis. Journal of Stroke and Cerebrovascular Diseases, 25(4), 894–901.
Barreto, A. D., Fanale, C. V., Alexandrov, A. V., Gaffney, K. C., Vahidy, F. S., Nguyen, C. B., et al. (2016, August). Prospective, open-label safety study of intravenous recombinant tissue plasminogen activator in wake-up stroke: Safety study of wake-up stroke thrombolysis. Annals of Neurology, 80(2), 211–218.
Green, A. R., & Shuaib, A. (2006, August). Therapeutic strategies for the treatment of stroke. Drug Discovery Today, 11(15–16), 681–693.
Fisher, M. (2011, January 1). New approaches to neuroprotective drug development. Stroke, 42, S24–S27.
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999, September). Pathobiology of ischaemic stroke: An integrated view. Trends in Neurosciences, 22(9), 391–397.
Mongin, A. A. (2007, December). Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm. Pathophysiology, 14(3–4), 183–193.
Simard, J. M., Kent, T. A., Chen, M., Tarasov, K. V., & Gerzanich, V. (2007, March). Brain oedema in focal ischaemia: Molecular pathophysiology and theoretical implications. The Lancet Neurology, 6(3), 258–268.
Chen, H., Yoshioka, H., Kim, G. S., Jung, J. E., Okami, N., Sakata, H., et al. (2011, April 15). Oxidative stress in ischemic brain damage: Mechanisms of cell death and potential molecular targets for neuroprotection. Antioxidants & Redox Signaling, 14(8), 1505–1517.
Sanderson, T. H., Reynolds, C. A., Kumar, R., Przyklenk, K., & Hüttemann, M. (2013, February). Molecular mechanisms of ischemia–reperfusion injury in brain: Pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Molecular Neurobiology, 47(1), 9–23.
Deb, P., Sharma, S., & Hassan, K. M. (2010, June). Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology, 17(3), 197–218.
Ford, A. L., An, H., Vo, K. D., Lin, W., & Lee, J.-M. (2012, June). Defining the ischemic penumbra using hyperacute neuroimaging: Deriving quantitative ischemic thresholds. Translational Stroke Research, 3(2), 198–204.
Kleinschnitz, C., Fluri, F., & Schuhmann, M. (2015). Animal models of ischemic stroke and their application in clinical research. Drug Design, Development and Therapy, 9, 3445.
Tamura, A., Graham, D. I., McCulloch, J., & Teasdale, G. M. (1981, March). Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. Journal of Cerebral Blood Flow & Metabolism, 1(1), 53–60.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989, January). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20(1), 84–91.
Schmid Elsaesser, R., Zausinger, S., Hungerhuber, E., Baethmann, A., & Reulen, H. J. (1998, October). A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: Evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke, 29(10), 2162–2170.
Belayev, L., Alonso, O. F., Busto, R., Zhao, W., Ginsberg, M. D., & Hsu, C. Y. (1996, September 1). Middle cerebral artery occlusion in the rat by intraluminal suture: Neurological and pathological evaluation of an improved model. Stroke, 27(9), 1616–1623.
Howells, D. W., Porritt, M. J., Rewell, S. S., O’Collins, V., Sena, E. S., Van der Worp, H. B., et al. (2010, August). Different strokes for different folks: The rich diversity of animal models of focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism, 30(8), 1412–1431.
Kuroiwa, T., Xi, G., Hua, Y., Nagaraja, T. N., Fenstermacher, J. D., & Keep, R. F. (2009, January 1). Development of a rat model of photothrombotic ischemia and infarction within the caudoputamen. Stroke, 40(1), 248–253.
Watson, B. D., Dietrich, W. D., Busto, R., Wachtel, M. S., & Ginsberg, M. D. (1985, May). Induction of reproducible brain infarction by photochemically initiated thrombosis. Annals of Neurology, 17(5), 497–504.
Yanagisawa, M., Kurihara, H., Kimura, S., Goto, K., & Masaki, T. (1988, December). A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. Journal of Hypertension, 6(4), S188–S191.
Hughes, P. M., Anthony, D. C., Ruddin, M., Botham, M. S., Rankine, E. L., Sablone, M., et al. (2003, December). Focal lesions in the rat central nervous system induced by endothelin-1. Journal of Neuropathology and Experimental Neurology, 62(12), 1276–1286.
Frost, S. B., Barbay, S., Mumert, M. L., Stowe, A. M., & Nudo, R. J. (2006, May). An animal model of capsular infarct: Endothelin-1 injections in the rat. Behavioural Brain Research, 169(2), 206–211.
Albers, G. W. (1995, February). Antithrombotic agents in cerebral ischemia. The American Journal of Cardiology, 75(6), 34B–38B.
DiNapoli, V. A., Rosen, C. L., Nagamine, T., & Crocco, T. (2006, June). Selective MCA occlusion: A precise embolic stroke model. Journal of Neuroscience Methods, 154(1–2), 233–238.
Zhang, Z., Zhang, R. L., Jiang, Q., Raman, S. B. K., Cantwell, L., & Chopp, M. (1997, February). A new rat model of thrombotic focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism, 17(2), 123–135.
Orset, C., Macrez, R., Young, A. R., Panthou, D., Angles-Cano, E., Maubert, E., et al. (2007, October 1). Mouse model of in situ thromboembolic stroke and reperfusion. Stroke, 38(10), 2771–2778.
Overgaard, K., Sereghy, T., Pedersen, H., & Boysen, G. (1994, May). Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. Journal of Cerebral Blood Flow and Metabolism, 14(3), 472–477.
Zhang, L., Zhang, Z. G., Zhang, C., Zhang, R. L., & Chopp, M. (2004, November 11). Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. Stroke, 35(12), 2890–2895.
Eskelinen, E. L. (2005, April). Maturation of autophagic vacuoles in mammalian cells. Autophagy, 1(1), 1–10.
Mijaljica, D., Prescott, M., & Devenish, R. J. (2011, July). Microautophagy in mammalian cells: Revisiting a 40-year-old conundrum. Autophagy, 7(7), 673–682.
PeriyasamyThandavan, S., Jiang, M., Schoenlein, P., & Dong, Z. (2009, August). Autophagy: Molecular machinery, regulation, and implications for renal pathophysiology. The American Journal of Physiology - Renal Physiology, 297(2), F244–F256.
Kiffin, R. (2004, September 1). Activation of chaperone-mediated autophagy during oxidative stress. Molecular Biology of the Cell, 15(11), 4829–4840.
Glick, D., Barth, S., & Macleod, K. F. (2010, May). Autophagy: Cellular and molecular mechanisms. The Journal of Pathology., 221(1), 3–12.
Marzella, L., Ahlberg, J., & Glaumann, H. (1981). Autophagy, heterophagy, microautophagy and crinophagy as the means for intracellular degradation. Virchows Archives B, Cell Pathology Including Molecular Pathology, 36(2–3), 219–234.
Klionsky, D. J. (2007, November). Autophagy: From phenomenology to molecular understanding in less than a decade. Nature Reviews Molecular Cell Biology, 8(11), 931–937.
Ravikumar, B., Sarkar, S., Davies, J. E., Futter, M., Garcia-Arencibia, M., Green-Thompson, Z. W., et al. (2010, October 1). Regulation of mammalian autophagy in physiology and pathophysiology. Physiological Reviews, 90(4), 1383–1435.
Gabryel, B., Kost, A., & Kasprowska, D. (2012). Neuronal autophagy in cerebral ischemia – a potential target for neuroprotective strategies? Pharmacological Reports, 64(1), 1–15.
Carloni, S., Girelli, S., Scopa, C., Buonocore, G., Longini, M., & Balduini, W. (2010, April). Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia. Autophagy, 6(3), 366–377.
Singh, A. K., Kashyap, M. P., Tripathi, V. K., Singh, S., Garg, G., & Rizvi, S. I. (2016). Neuroprotection through rapamycin-induced activation of autophagy and PI3K/Akt1/mTOR/CREB signaling against amyloid-β-induced oxidative stress, synaptic/neurotransmission dysfunction, and neurodegeneration in adult rats. Molecular Neurobiology. Available from: http://link.springer.com/10.1007/s12035-016-0129-3.
Wang, P., Guan, Y. F., Du, H., Zhai, Q. W., Su, D. F., & Miao, C. Y. (2012, January). Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy, 8(1), 77–87.
Adhami, F., Liao, G., Morozov, Y. M., Schloemer, A., Schmithorst, V. J., Lorenz, J. N., et al. (2006, August). Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy. The American Journal of Pathology, 169(2), 566–583.
Li, J., & McCullough, L. D. (2010, March). Effects of AMP-activated protein kinase in cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism, 30(3), 480–492.
Koike, M., Shibata, M., Tadakoshi, M., Gotoh, K., Komatsu, M., Waguri, S., et al. (2008, February). Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury. The American Journal of Pathology, 172(2), 454–469.
Wen, Y. D., Sheng, R., Zhang, L. S., Han, R., Zhang, X., Zhang, X. D., et al. (2008, August 16). Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy, 4(6), 762–769.
Xin, X. Y., Pan, J., Wang, X. Q., Ma, J. F., Ding, J. Q., Yang, G. Y., et al. (2011, July). 2-methoxyestradiol attenuates autophagy activation after global ischemia. Canadian Journal of Neurological Sciences/Journal Canadien des Sciences Neurologiques, 38(04), 631–638.
Kang, C., & Avery, L. (2008, January). To be or not to be, the level of autophagy is the question: Dual roles of autophagy in the survival response to starvation. Autophagy, 4(1), 82–84.
Shi, R., Weng, J., Zhao, L., Li, X. M., Gao, T. M., & Kong, J. (2012, March). Excessive autophagy contributes to neuron death in cerebral ischemia: Autophagy in cerebral ischemia. CNS Neuroscience & Therapeutics, 18(3), 250–260.
Qin, A. P., Liu, C. F., Qin, Y. Y., Hong, L. Z., Xu, M., Yang, L., et al. (2010, August). Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia. Autophagy, 6(6), 738–753.
Tu, X., Yang, W., Chen, J., Chen, Y., Chen, Q., Chen, P., et al. (2015, April). Repetitive ischemic preconditioning attenuates inflammatory reaction and brain damage after focal cerebral ischemia in rats: Involvement of PI3K/Akt and ERK1/2 signaling pathway. Journal of Molecular Neuroscience, 55(4), 912–922.
Park, H. K., Chu, K., Jung, K. H., Lee, S. T., Bahn, J. J., Kim, M., et al. (2009, February). Autophagy is involved in the ischemic preconditioning. Neuroscience Letters, 451(1), 16–19.
Yan, W., Zhang, H., Bai, X., Lu, Y., Dong, H., & Xiong, L. (2011, July). Autophagy activation is involved in neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats. Brain Research, 1402, 109–121.
Carloni, S., Buonocore, G., & Balduini, W. (2008, December). Protective role of autophagy in neonatal hypoxia–ischemia induced brain injury. Neurobiology of Disease, 32(3), 329–339.
Komatsu, M., Ueno, T., Waguri, S., Uchiyama, Y., Kominami, E., & Tanaka, K. (2007, March). Constitutive autophagy: Vital role in clearance of unfavorable proteins in neurons. Cell Death and Differentiation. Available from: http://www.nature.com/doifinder/10.1038/sj.cdd.4402120.
Liu, C., Gao, Y., Barrett, J., & Hu, B. (2010, October). Autophagy and protein aggregation after brain ischemia. Journal of Neurochemistry, 115(1), 68–78.
Acknowledgement
A. K. Singh would like to acknowledge University Grants Commission, New Delhi, India, for providing financial support (F.4-2/2006(BSR)/BL/14-15/0326).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Saraswat, K., Kumar, R., Rizvi, S.I., Singh, A.K. (2019). The Role of Autophagy in Ischaemic Stroke: Friend or Foe?. In: Patnaik, R., Tripathi, A., Dwivedi, A. (eds) Advancement in the Pathophysiology of Cerebral Stroke. Springer, Singapore. https://doi.org/10.1007/978-981-13-1453-7_5
Download citation
DOI: https://doi.org/10.1007/978-981-13-1453-7_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1452-0
Online ISBN: 978-981-13-1453-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)